Paragon Care Limited
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provi… Read more
Market Cap & Net Worth: Paragon Care Limited (PXS)
Paragon Care Limited (F:PXS) has a market capitalization of $169.91 Million (€165.53 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #21011 globally and #2273 in its home market, demonstrating a -7.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Paragon Care Limited's stock price €0.10 by its total outstanding shares 1655305389 (1.66 Billion).
Paragon Care Limited Market Cap History: 2015 to 2026
Paragon Care Limited's market capitalization history from 2015 to 2026. Data shows change from $471.17 Million to $169.91 Million (-9.00% CAGR).
Paragon Care Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Paragon Care Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.17x
Paragon Care Limited's market cap is 0.17 times its annual revenue
0.29x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
58.79x
Paragon Care Limited's market cap is 58.79 times its annual earnings
9.22x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $471.17 Million | $32.22 Million | $2.10 Million | 14.62x | 224.03x |
| 2016 | $627.15 Million | $93.30 Million | $7.53 Million | 6.72x | 83.28x |
| 2017 | $627.15 Million | $117.14 Million | $10.17 Million | 5.35x | 61.64x |
| 2018 | $506.00 Million | $136.50 Million | $10.95 Million | 3.71x | 46.21x |
| 2019 | $359.70 Million | $236.09 Million | -$14.39 Million | 1.52x | N/A |
| 2020 | $184.02 Million | $231.69 Million | -$77.27 Million | 0.79x | N/A |
| 2021 | $326.23 Million | $235.84 Million | $8.28 Million | 1.38x | 39.40x |
| 2022 | $281.72 Million | $247.91 Million | $7.14 Million | 1.14x | 39.43x |
| 2023 | $215.79 Million | $307.63 Million | $10.76 Million | 0.70x | 20.05x |
| 2024 | $492.75 Million | $2.97 Billion | $8.38 Million | 0.17x | 58.79x |
Competitor Companies of PXS by Market Capitalization
Companies near Paragon Care Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Paragon Care Limited by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #164 globally with a market cap of $115.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #340 globally with a market cap of $64.39 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #428 globally with a market cap of $51.10 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1455 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | McKesson Corporation | NYSE:MCK | $115.38 Billion | $943.25 |
| #340 | Cencora Inc. | NYSE:COR | $64.39 Billion | $345.88 |
| #428 | Cardinal Health Inc | NYSE:CAH | $51.10 Billion | $217.59 |
| #1455 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Paragon Care Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Paragon Care Limited's market cap moved from $471.17 Million to $ 169.91 Million, with a yearly change of -9.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €169.91 Million | -10.71% |
| 2025 | €190.30 Million | -61.38% |
| 2024 | €492.75 Million | +128.35% |
| 2023 | €215.79 Million | -23.40% |
| 2022 | €281.72 Million | -13.65% |
| 2021 | €326.23 Million | +77.29% |
| 2020 | €184.02 Million | -48.84% |
| 2019 | €359.70 Million | -28.91% |
| 2018 | €506.00 Million | -19.32% |
| 2017 | €627.15 Million | 0.00% |
| 2016 | €627.15 Million | +33.10% |
| 2015 | €471.17 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Paragon Care Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $169.91 Million USD |
| MoneyControl | $169.91 Million USD |
| MarketWatch | $169.91 Million USD |
| marketcap.company | $169.91 Million USD |
| Reuters | $169.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.